Atherogenic Lipoprotein Particles in Atherosclerosis

Circulation - United States
doi 10.1161/01.cir.0000131511.50734.44
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Atherogenic Dyslipidemia in Diabetic Nephropathy: Lipoprotein (A), Lipid Ratios and Atherogenic Index

International Journal of Research in Medical Sciences
2013English

Lipoprotein Particles and Incident Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Energy Substrate Partitioning and Efficiency in Individuals With Atherogenic Lipoprotein Phenotype

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2011English

Oxidized Low-Density Lipoprotein and Atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2010English

The Lipoprotein Particles in Cow's Milk

Biochemical Journal
1954English

Investigating the Atherogenic Risk of Lipoprotein(a) in Type 2 Diabetic Patients

Cureus
2018English

Lipidomics of Plasma High-Density Lipoprotein: Insights Into Anti-Atherogenic Function

Journal of Glycomics & Lipidomics
2015English

Prevalence and Predictors of Atherogenic Serum Lipoprotein Dyslipidemia in Women With Obstructive Sleep Apnea

Scientific Reports
Multidisciplinary
2017English

Atherogenic Low Density Lipoprotein Phenotype in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy